search_api_autocomplete
Home

Press release on the suspension of trading in Mithra Pharmaceuticals

Press release
Suspension of a share: representation of  a share price with graphs and figures

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017

Trading in the financial instruments of Mithra Pharmaceuticals, ISIN BE0974283153, on Euronext Brussels is suspended on the request of the company from 30/10/2023 at 13:30 CET until the publication of a press release.